Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer – study protocol for a randomized control trial

BACKGROUND: Despite optimal surgery and appropriate first-line chemotherapy, ∼70–80 % of patients with epithelial ovarian cancer will develop disease relapse. The prognosis is poor especially for women with Platinum resistant ovarian cancer. The standard treatment for these groups of patients is non...

Descripción completa

Detalles Bibliográficos
Autores principales: Somashekhar, S. P., Ashwin, K. R., Rauthan, Amit, Rohit, Kumar C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545874/
https://www.ncbi.nlm.nih.gov/pubmed/31198851
http://dx.doi.org/10.1515/pp-2018-0111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545874/
https://www.ncbi.nlm.nih.gov/pubmed/31198851
http://dx.doi.org/10.1515/pp-2018-0111

Ejemplares similares